Cancer

Study IDs key protein for cell deathFindings may offer a new way to kill cancer cells by forcing them into an alternative programmed-death pathway.

A different view of cancer cellsNew study measures physical changes in tumor cells as they become metastatic.

Study reveals how melanoma evades chemotherapyDrugs that block nitric oxide could weaken cancer cells’ resistance, researchers say.

How to minimize the side effects of cancer treatmentMeasuring enzyme levels in patients may reveal healthy cells’ ability to survive chemotherapy.

Practicing medicine at the nanoscaleNew approaches to drug delivery offer hope for new, more targeted treatments.

Research update: Chemists find help from nature in fighting cancerStudy of several dozen compounds based on a fungal chemical shows potent anti-tumor activity.

Some cancer mutations slow tumor growthSurprising result suggests that enhancing these mutations’ impact could offer a new way to treat cancer.

Tiny tools help advance medical discoveriesMIT researchers are designing tools to analyze cells at the microscale.

Professor Roger Kamm visualizes sneaky tumor cells with 3-D assayKamm is studying the mechanics of metastasis, the process of cancer-cell migration from one location in the body to another and the cause of more than 90 percent of cancer deaths.

Improving the accuracy of cancer diagnosesNew spectroscopy technique could help doctors better identify breast tumors.

New technology may enable earlier cancer diagnosisNanoparticles amplify tumor signals, making them much easier to detect in the urine.

Tissue engineering: Growing new organs, and moreResearch could lead to better ways to heal injuries and develop new drugs.

On the hunt for rare cancer cellsJellyfish-inspired device that rapidly and efficiently captures cancer cells from blood samples could enable better patient monitoring.

How cancer cells break free from tumorsNew MIT study identifies adhesion molecules key to cancer’s spread through the body.

How better financing could help create new cancer drugsMIT finance researchers say a diversified ‘megafund’ of securities could help the industry deliver new products to consumers.

Turning on key enzyme blocks tumor formationDrug-like molecule restores normal cell metabolism, preventing cancer cells from growing.

New nanoparticles shrink tumors in miceParticles that shut off cancer genes could also allow researchers to screen potential drug targets more rapidly.

New drug candidate shows promise against cancerPlatinum compound may offer an alternative to cisplatin, a widely used chemotherapy agent.

Study identifies enzymes needed to mend tissue damage after inflammationFindings may help predict colon cancer risk for patients with inflammatory bowel disease.

How infection can lead to cancerNew MIT study offers comprehensive look at chemical and genetic changes that occur as inflammation progresses to cancer.

Researchers achieve RNA interference, in a lighter packagePared-down nucleic acid nanoparticle poses less risk of side effects, offers better targeting.

One-two punch knocks out aggressive breast cancer cellsNew MIT study shows that staggered delivery of cancer drugs is far more effective than administering them at the same time.

Nano-sized ‘factories’ churn out proteinsTiny particles could manufacture cancer drugs at tumor sites.

Targeted nanoparticles show success in clinical trialsTiny particles designed to home in on cancer cells achieve tumor shrinkage at lower doses than traditional chemotherapy.

Freeing radicals from their negative connotationsKillian Award recipient JoAnne Stubbe says some free radicals can be good for you.

Delivering RNA with tiny sponge-like spheresNew RNA interference method holds promise for treating cancer, other diseases.